152 related articles for article (PubMed ID: 32116106)
1. Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma.
Correa AF; Ruth KJ; Al-Saleem T; Pei J; Dulaimi E; Kister D; Collins M; Abbosh PH; Slifker MJ; Ross E; Uzzo RG; Testa JR
Cancer Biol Ther; 2020 May; 21(5):424-431. PubMed ID: 32116106
[TBL] [Abstract][Full Text] [Related]
2. Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
Fernandes FG; Silveira HCS; Júnior JNA; da Silveira RA; Zucca LE; Cárcano FM; Sanches AON; Neder L; Scapulatempo-Neto C; Serrano SV; Jonasch E; Reis RM; Evangelista AF
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668731
[TBL] [Abstract][Full Text] [Related]
3. Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization.
Reutzel D; Mende M; Naumann S; Störkel S; Brenner W; Zabel B; Decker J
Cytogenet Cell Genet; 2001; 93(3-4):221-7. PubMed ID: 11528115
[TBL] [Abstract][Full Text] [Related]
4. Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification.
Yoshikawa Y; Yamada Y; Emi M; Atanesyan L; Smout J; de Groot K; Savola S; Nakanishi-Shinkai Y; Kanematsu A; Nojima M; Ohmuraya M; Hashimoto-Tamaoki T; Yamamoto S
Cancer Sci; 2022 Jan; 113(1):297-307. PubMed ID: 34687579
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
[TBL] [Abstract][Full Text] [Related]
6. Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma.
Nejati R; Wei S; Uzzo RG; Poureghbali S; Pei J; Talarchek JN; Ruth K; Dulaimi E; Kutikov A; Testa JR; Al-Saleem T
Clin Genitourin Cancer; 2020 Feb; 18(1):56-61. PubMed ID: 31648964
[TBL] [Abstract][Full Text] [Related]
7. Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.
Hakimi AA; Ostrovnaya I; Jacobsen A; Susztak K; Coleman JA; Russo P; Winer AG; Mano R; Sankin AI; Motzer RJ; Voss MH; Offit K; Purdue M; Pomerantz M; Freedman M; Choueiri TK; Hsieh JJ; Klein RJ
Cancer; 2016 Feb; 122(3):402-10. PubMed ID: 26505625
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
[TBL] [Abstract][Full Text] [Related]
9. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
[TBL] [Abstract][Full Text] [Related]
10. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
[TBL] [Abstract][Full Text] [Related]
11. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
[TBL] [Abstract][Full Text] [Related]
12. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
13. Predictive chromosomal clusters of synchronous and metachronous brain metastases in clear cell renal cell carcinoma.
Gutenberg A; Nischwitz MD; Gunawan B; Enders C; Jung K; Bergmann M; Feiden W; Egensperger R; Keyvani K; Stolke D; Sure U; Schroeder HW; Warzok R; Schober R; Meixensberger J; Paulus W; Wassmann H; Stummer W; Blumcke I; Buchfelder M; van Landeghem FK; Vajkoczy P; Günther M; Bedke J; Giese A; Rohde V; Brück W; Füzesi L; Sander B
Cancer Genet; 2014 May; 207(5):206-13. PubMed ID: 25027636
[TBL] [Abstract][Full Text] [Related]
14. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression.
Marcon J; DiNatale RG; Sanchez A; Kotecha RR; Gupta S; Kuo F; Makarov V; Sandhu A; Mano R; Silagy AW; Blum KA; Nassau DE; Benfante NE; Ortiz MV; Carlo MI; Chan TA; Motzer RJ; Voss MH; Coleman J; Russo P; Reuter V; Hakimi AA; Reznik E
Clin Cancer Res; 2020 Jul; 26(14):3629-3640. PubMed ID: 32220885
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma.
Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Darwish OM; Haddad AQ; Khalil D; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
J Urol; 2014 Jun; 191(6):1671-7. PubMed ID: 24291548
[TBL] [Abstract][Full Text] [Related]
17. Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features.
Ito T; Pei J; Dulaimi E; Menges C; Abbosh PH; Smaldone MC; Chen DY; Greenberg RE; Kutikov A; Viterbo R; Uzzo RG; Testa JR
J Urol; 2016 Apr; 195(4 Pt 1):852-8. PubMed ID: 26602888
[TBL] [Abstract][Full Text] [Related]
18. Patterns of aneuploidy in stage IV clear cell renal cell carcinoma revealed by comparative genomic hybridization and spectral karyotyping.
Pavlovich CP; Padilla-Nash H; Wangsa D; Nickerson ML; Matrosova V; Linehan WM; Ried T; Phillips JL
Genes Chromosomes Cancer; 2003 Jul; 37(3):252-60. PubMed ID: 12759923
[TBL] [Abstract][Full Text] [Related]
19. Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma.
Sgambato A; Camerini A; Amoroso D; Genovese G; De Luca F; Cecchi M; Migaldi M; Rettino A; Valsuani C; Tartarelli G; Donati S; Siclari O; Rossi G; Cittadini A
Cancer Biol Ther; 2007 Dec; 6(12):1840-6. PubMed ID: 18087214
[TBL] [Abstract][Full Text] [Related]
20. Copy Number Alterations with Prognostic Potential in Clear Cell Renal Cell Carcinoma.
Maruschke M; Koczan D; Ziems B; Hakenberg OW
Urol Int; 2018; 101(4):417-424. PubMed ID: 30227442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
